NDC product
Dextromethorphan hydrobromide and quinidine sulfate
NDC 0480-2602 · Teva Pharmaceuticals, Inc.
Key facts
| Product NDC | 0480-2602 |
|---|---|
| Proprietary name | Dextromethorphan hydrobromide and quinidine sulfate |
| Nonproprietary name | Dextromethorphan hydrobromide and quinidine sulfate |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE, QUINIDINE SULFATE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Teva Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA202934 |
| Pharmacologic classes | Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] and 1 more |
| Marketing start | Sep 16, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: